Treatment decisions for chronic lymphocytic leukemia (CLL) and chronic myelocytic leukemia (CML) are complex. Recent advancements in CLL classification aid therapeutic clarity, while CML chemotherapy manages symptoms but doesn't significantly extend survival.
Area of Science:
You might also read
Articles linked to this work by shared authors, journal, and citation graph.